Kottilil S - Search Results

1

A pilot study to expand treatment of chronic hepatitis C in resource-limited settings.

Mathur P, Comstock E, McSweegan E, Mercer N, Kumar NS, Kottilil S. Mathur P, et al. Among authors: kottilil s. Antiviral Res. 2017 Oct;146:184-190. doi: 10.1016/j.antiviral.2017.09.007. Epub 2017 Sep 18. Antiviral Res. 2017. PMID: 28927676

2

Dual sofosbuvir and ribavirin therapy for chronic hepatitis C infection.

Tang L, Ward H, Kattakuzhy S, Wilson E, Kottilil S. Tang L, et al. Among authors: kottilil s. Expert Rev Gastroenterol Hepatol. 2016;10(1):21-36. doi: 10.1586/17474124.2016.1119042. Epub 2015 Dec 11. Expert Rev Gastroenterol Hepatol. 2016. PMID: 26558305 Review.

3

Elbasvir/grazoprevir for treatment of chronic hepatitis C virus infection.

Papudesu C, Kottilil S, Bagchi S. Papudesu C, et al. Among authors: kottilil s. Hepatol Int. 2017 Mar;11(2):152-160. doi: 10.1007/s12072-016-9761-2. Epub 2016 Sep 13. Hepatol Int. 2017. PMID: 27624503 Review.

4

Effects of ribavirin/sofosbuvir treatment and ITPA phenotype on endogenous purines.

Jimmerson LC, Clayton CW, MaWhinney S, Meissner EG, Sims Z, Kottilil S, Kiser JJ. Jimmerson LC, et al. Among authors: kottilil s. Antiviral Res. 2017 Feb;138:79-85. doi: 10.1016/j.antiviral.2016.12.005. Epub 2016 Dec 9. Antiviral Res. 2017. PMID: 27956135 Free PMC article.

5

Augmentation of hepatitis C virus-specific immunity and sustained virologic response.

Shrivastava S, Wilson E, Poonia B, Tang L, Osinusi A, Kohli A, Kottilil S. Shrivastava S, et al. Among authors: kottilil s. J Viral Hepat. 2017 Sep;24(9):742-749. doi: 10.1111/jvh.12702. Epub 2017 May 4. J Viral Hepat. 2017. PMID: 28267900 Free PMC article. Clinical Trial.

6

Vedroprevir in the management of hepatitis C virus infection.

Abutaleb A, Kottilil S. Abutaleb A, et al. Among authors: kottilil s. Expert Opin Investig Drugs. 2017 Dec;26(12):1399-1402. doi: 10.1080/13543784.2017.1395412. Epub 2017 Oct 26. Expert Opin Investig Drugs. 2017. PMID: 29053394 Free PMC article. Review.

7

Transcriptional profiling of PBMCs unravels B cell mediated immunopathogenic imprints of HCV vasculitis.

Comstock E, Kim CW, Murphy A, Emmanuel B, Zhang X, Sneller M, Poonia B, Kottilil S. Comstock E, et al. Among authors: kottilil s. PLoS One. 2017 Dec 11;12(12):e0188314. doi: 10.1371/journal.pone.0188314. eCollection 2017. PLoS One. 2017. PMID: 29228031 Free PMC article.

8

Recovery of hepatitis C specific T-cell responses after rituximab therapy in hepatitis C mixed cryoglobulinemic vasculitis.

Mathur P, Emmanuel B, Sneller M, Zhang X, Poonia B, Kottilil S. Mathur P, et al. Among authors: kottilil s. J Med Virol. 2018 May;90(5):936-941. doi: 10.1002/jmv.25002. Epub 2018 Jan 4. J Med Virol. 2018. PMID: 29236302 Free PMC article. Clinical Trial.

9

Implementation of a unique hepatitis C care continuum model in Rwanda.

Mathur P, Comstock E, Makuza JD, Emmanuel B, Sebeza J, Kiromera A, Wilson E, Kattakuzhy S, Nelson A, Kottilil S, Riedel DJ. Mathur P, et al. Among authors: kottilil s. J Public Health (Oxf). 2019 Jun 1;41(2):e203-e208. doi: 10.1093/pubmed/fdy115. J Public Health (Oxf). 2019. PMID: 29982813

10

Sofosbuvir/velpatasvir/voxilaprevir: a highly effective option for retreatment of hepatitis C in difficult-to-treat patients.

Mathur P, Kottilil S, Wilson E. Mathur P, et al. Among authors: kottilil s. Antivir Ther. 2019;24(1):1-10. doi: 10.3851/IMP3264. Antivir Ther. 2019. PMID: 30210057 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

297 results

Search Page